Have a personal or library account? Click to login
Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy Cover

Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy

Radiology and Oncology
Volume 56 (2022): Issue 2 (June 2022)
By:
Open Access
|Feb 2022

Metrics

DOI: https://doi.org/10.2478/raon-2022-0006 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 228 - 237
Submitted on: Nov 2, 2021
Accepted on: Jan 13, 2022
Published on: Feb 25, 2022
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
chemoradiotherapy,
Glasgow prognostic score,
locally advanced non-small cell lung cancer,
overall survival,
post-progression survival,
progression-free survival
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2022 Hisao Imai, Daijiro Kobayashi, Kyoichi Kaira, Sayaka Kawashima, Ken Masubuchi, Masumi Murata, Takeshi Ebara, Yoshizumi Kitamoto, Koichi Minato, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 56 (2022): Issue 2 (June 2022)Next article